Fortress Biotech (FBIO) Reports Q2 Loss, Lags Revenue Estimates

Fortress Biotech (FBIO) came out with a quarterly loss of $0.73 per share versus the Zacks Consensus Estimate of a loss of$ 1.32. This compares to loss of $3.60 per share a year ago. These figures are adjusted for nonrecurring items. This quarterly report represents an earnings surprise of 44.70%. A quarter ago, it was expected that this biopharmaceutical company would post a loss of$ 2.03 per share when it actually produced a loss of $1.03, delivering a surprise of 49.26%. Over the last four quarters, the ...